PMC6388320_01
The figure shows appearance of the right elbow mass. The mass is of 3 x 2 x 4 cm.
CRIOR2019-8762614.001.jpg
PMC6388320_01_CRIOR2019-8762614.001.jpg
fig1
Physical examination revealed a 3 x 2 x 4 cm mobile soft nontender mass extending from the right proximal ulnar aspect volar surface crossing the elbow crease proximally with no signs of erythema (Figure 1).
Plain radiograph AP view of the right elbow showed lobular soft tissue swelling suggesting a mass.
CRIOR2019-8762614.002.jpg
PMC6388320_01_CRIOR2019-8762614.002.jpg
fig2
MRI of the right elbow: coronal T2-W1 sagittal T2-W1 sequences of the right elbow shows a lobular juxta articular subcutaneous soft tissue lesion along the medial aspect of the elbow; the lesion appears multiseptated with a predominantly high T2 signal intensity.
CRIOR2019-8762614.003.jpg
PMC6388320_01_CRIOR2019-8762614.003.jpg
fig3
The lesion appeared multiseptated with a predominantly high T2 signal intensity and contains a 1.8 x 1.8 x 1.5 cm area with low T2 and high T1 signal intensity and no perilesional edema or joint effusion (Figures 3 and 4).
MRI of the right elbow axial T1-W1 (a) and T2-W1 (b) intramass 1.8 x 1.8 x 1.5 cm area with low T2 and high T1 signal intensity.
CRIOR2019-8762614.004.jpg
PMC6388320_01_CRIOR2019-8762614.004.jpg
fig4
The lesion appeared multiseptated with a predominantly high T2 signal intensity and contains a 1.8 x 1.8 x 1.5 cm area with low T2 and high T1 signal intensity and no perilesional edema or joint effusion (Figures 3 and 4).
Intra-op capture for the dissection of the mass from the median nerve.
CRIOR2019-8762614.005.jpg
PMC6388320_01_CRIOR2019-8762614.005.jpg
fig5
Right elbow lesion showed multiloculated lymphangioma with no evidence of malignancy. The lesion shows vascular spaces with thick vascular walls incorporating adipose tissue and nerve fascicles (H&E, x200).
CRIOR2019-8762614.006.jpg
PMC6388320_01_CRIOR2019-8762614.006.jpg
fig6
Pathology specimen of the tumor showed a multiloculated lymphangioma with no evidence of malignancy (Figure 6).